These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2096184)

  • 1. Identifying and responding to drug abuse in the workplace: an overview.
    Seymour RB; Smith DE
    J Psychoactive Drugs; 1990; 22(4):383-405. PubMed ID: 2096184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance abuse in the workplace: epidemiology, effects, and industry response.
    Bush DM; Autry JH
    Occup Med; 2002; 17(1):13-25, iii. PubMed ID: 11726333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicines and drug testing in the workplace.
    DuPont RL
    J Psychoactive Drugs; 1990; 22(4):451-9. PubMed ID: 2096190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical dependency and drug testing in the workplace.
    Osterloh JD; Becker CE
    J Psychoactive Drugs; 1990; 22(4):407-17. PubMed ID: 2096185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM
    Forensic Sci Int; 2008 Jan; 174(2-3):111-9. PubMed ID: 17434274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview on drug and alcohol testing in the workplace.
    Hanson M
    Bull Narc; 1993; 45(2):3-44. PubMed ID: 7920541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Random drug tests at work: the probability of identifying frequent and infrequent users of illicit drugs.
    DuPont RL; Griffin DW; Siskin BR; Shiraki S; Katze E
    J Addict Dis; 1995; 14(3):1-17. PubMed ID: 8555274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the EAP in the identification and treatment of substance abuse.
    Kramer RM
    Clin Lab Med; 1998 Dec; 18(4):747-53, x. PubMed ID: 9891612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-free workplace programmes: New Zealand perspective.
    Nolan S
    Forensic Sci Int; 2008 Jan; 174(2-3):125-32. PubMed ID: 17467938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Workers with alcohol and drug addiction problems. Consensus Document of the Study Group on Hazardous Workers].
    Magnavita N; Bergamaschi A; Chiarotti M; Colombi A; Deidda B; De Lorenzo G; Goggiamani A; Magnavita G; Ricciardi W; Sacco A; Spagnolo AG; Bevilacqua L; Brunati MM; Campanile T; Cappai M; Cicerone M; Ciprani F; Di Giannantonio M; Di Martino G; Fenudi L; Garbarino S; Lopez A; Mammi F; Orsini D; Ranalletta D; Simonazzi S; Stanzani C
    Med Lav; 2008; 99 Suppl 2():3-58. PubMed ID: 19248471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral fluid testing: new technology enables drug testing without embarrassment.
    Cone EJ
    J Calif Dent Assoc; 2006 Apr; 34(4):311-5. PubMed ID: 16900989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Legal issues facing physicians: substance abuse in the workplace.
    Clark HW; Johnson B
    Occup Med; 2002; 17(1):119-35, v. PubMed ID: 11726341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence of licit and illicit drugs in police stations and their implications for workplace drug testing.
    Doran GS; Deans R; De Filippis C; Kostakis C; Howitt JA
    Forensic Sci Int; 2017 Sep; 278():125-136. PubMed ID: 28715674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance abuse and criminality.
    Sinha R; Easton C
    J Am Acad Psychiatry Law; 1999; 27(4):513-26. PubMed ID: 10638781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical dependency and drug testing in the workplace.
    Osterloh JD; Becker CE
    West J Med; 1990 May; 152(5):506-13. PubMed ID: 2190418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric properties of the Drug Use Disorders Identification Test (DUDIT) with substance abusers in outpatient and residential treatment.
    Voluse AC; Gioia CJ; Sobell LC; Dum M; Sobell MB; Simco ER
    Addict Behav; 2012 Jan; 37(1):36-41. PubMed ID: 21937169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A protocol to evaluate drug-related workplace impairment.
    Reisfield GM; Shults T; Demery J; Dupont R
    J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):43-8. PubMed ID: 23527668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs and alcohol in the workplace.
    Conry PB
    AAOHN J; 1991 Oct; 39(10):461-5. PubMed ID: 1930379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug testing in the workplace: integrating medical review officer duties into occupational medicine.
    Smith DE; Glatt W; Tucker DE; Deutsch R; Seymour RB
    Occup Med; 2002; 17(1):79-90, v. PubMed ID: 11726338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of physicians as medical review officers in workplace drug testing programs. In pursuit of the last nanogram.
    Clark HW
    West J Med; 1990 May; 152(5):514-24. PubMed ID: 2190419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.